FDA/CDC

Stryker issues voluntary field action for Lifepak 15 defibrillators


 

Stryker has announced a voluntary field action for its Lifepak 15 monitor/defibrillators, according to a safety alert from the Food and Drug Administration.

FDA icon Wikimedia Commons/FitzColinGerald/Creative Commons License

The company is notifying certain Lifepak 15 customers of an issue causing the device to lock up after a defibrillation shock is delivered. The lockup displays as a blank monitor with the LED lights on, indicating that the power is on, but the keypad and device become nonfunctional, the FDA said. This lockup can delay delivery of therapy, which can cause injury or death.

Since the introduction of the device in 2009, 58 complaints regarding the issue have been reported, including 6 that resulted in death. In all, 13,003 devices are included in the field action.

Customers should continue to use their devices if they have been affected until a correction can be completed. If the lockup occurs, the user should press and hold the “on” button until the LED turns off, then hit the “on” button again. If this does not reset the device, the batteries should be removed and reinserted, or the device should be removed and reconnected to its power adapter, the FDA said.

Find the full press release on the FDA website.

Recommended Reading

Data support revising ASCVD cardiovascular risk threshold
MDedge Internal Medicine
AHA promises practice-changing late breakers
MDedge Internal Medicine
ICYMI: Alirocumab improves cardiovascular outcomes
MDedge Internal Medicine
Quality tool tied to improved adherence
MDedge Internal Medicine
Is prehospital cooling in cardiac arrest ready for prime time?
MDedge Internal Medicine
Heart disease remains the leading cause of death in U.S.
MDedge Internal Medicine
Phone app diagnoses STEMI nearly as well as ECG
MDedge Internal Medicine
Digital alerts reduced AF-related stroke, MI rates
MDedge Internal Medicine
Can higher MAP post cardiac arrest improve neurologic outcomes?
MDedge Internal Medicine
Hospital Readmissions Reduction Program may be doing more harm than good
MDedge Internal Medicine